Medicofarma Biotech SA
WSE:MDB
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.377
1.225
|
Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Gross Margin
Medicofarma Biotech SA
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | PL |
Market Cap | 25.6m PLN |
Gross Margin |
86%
|
Country | US |
Market Cap | 1.3T USD |
Gross Margin |
55%
|
Country | US |
Market Cap | 196.3B USD |
Gross Margin |
41%
|
Country | US |
Market Cap | 170.3B USD |
Gross Margin |
60%
|
Country | KR |
Market Cap | 66.5T KRW |
Gross Margin |
50%
|
Country | CH |
Market Cap | 37.6B CHF |
Gross Margin |
29%
|
Country | US |
Market Cap | 38.5B USD |
Gross Margin |
55%
|
Country | US |
Market Cap | 36.7B USD |
Gross Margin |
35%
|
Country | US |
Market Cap | 26.4B USD |
Gross Margin |
59%
|
Country | US |
Market Cap | 23B USD |
Gross Margin |
35%
|
Country | US |
Market Cap | 22.3B USD |
Gross Margin |
64%
|
Medicofarma Biotech SA
Glance View
Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Medicofarma Biotech SA's most recent financial statements, the company has Gross Margin of 85.6%.